Log In
Print this Print this

cobas EGFR Mutation Test

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionReal-time PCR-based companion diagnostic test that detects 41 mutations across exons 18, 19, 20 and 21 of the EGFR gene
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose EGFR mutations in patients with non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today